3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Pain
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Papillomavirus Infections
1
Carcinoma in Situ
1
Breast Diseases
1
Agnosia
1
Interventions
Ropivacaine
6
Anesthesia, General
6
Analgesics, Opioid
6
Morphine
5
Acetaminophen
5
Saline Solution
4
Lidocaine
4
Ketamine
4
Fentanyl
4
Sodium Chloride
3
Dexmedetomidine
3
Bupivacaine
3
Anesthetics, Local
3
Anesthesia, Local
3
Acupuncture Therapy
3
trimebutine 3-thiocarbamoylbenzenesulfonate
2
parecoxib
2
Transcutaneous Electric Nerve Stimulation
2
Tramadol
2
Therapeutics
2
Tea
2
Surveys and Questionnaires
2
Propofol
2
Oxycodone
2
Magnesium Sulfate
2
Levobupivacaine
2
Control Groups
2
ramosetron
1
acetaminophen, codeine drug combination
1
Varenicline
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Agnosia
×
Codeine
×
Clear all
NCT00299039
2009-02-02
T3AI
Nova Scotia Health Authority
Phase 3
Completed
150 enrolled